NuCana plc (NCNA) Financials
NCNA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 41.4 million | 14.9 million |
2023-06-30 | 52.1 million | 17.5 million |
2023-03-31 | 72.2 million | 24.5 million |
2022-12-31 | 70.5 million | 23.9 million |
NCNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.5 million | 1.1 million |
2023-06-30 | -7.6 million | 1.3 million |
2023-03-31 | -8.5 million | 1.2 million |
2022-12-31 | -8.3 million | 1.2 million |
NCNA Net Income
No data available :(
NCNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 21.7 million | - | 551304 |
2023-06-30 | 31.1 million | - | 713286 |
2023-03-31 | 51.9 million | - | 745884 |
2022-12-31 | 50.7 million | - | 773281 |
NCNA Shares Outstanding
NCNA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 103674 | 9.1 million | 1.7 million | - |
2023-06-30 | 172956 | 5.0 million | 2.2 million | - |
2023-03-31 | 136291 | 16.3 million | 1.9 million | - |
2022-12-31 | 133115 | 16.0 million | 1.9 million | - |
NCNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
NCNA
Price: $4
52 week price:
Earnings Per Share: -0.67 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 46300
Market Capitalization: 12.5 million